RNA polymerase II is lovingly called “Pol II” by biologists. It’s an unassuming name (maybe a sequel to a blockbuster about a politician or a poltergeist) for a protein that is one of the most central and essential machines of eukaryotic life. Pol II is the main player in transcription, the process by which DNA sequences are read into messenger RNA. It’s hard to imagine a cell staying alive without it, and in fact “prolonged inhibition of RNA Pol II is expected to be universally lethal.” That’s a quote from a new paper in Cell that shows why Pol II inhibition is lethal. That might sound like a question with an obvious answer. But it’s not.
The reasonable supposition is (was) that inhibiting Pol II means no mRNA, which means no protein, which causes uninteresting death as the ongoing depletion leads to “some unavoidable catastrophic event.” But the thing is: cells are really good at adjusting to big changes in mRNA levels. Could it be that cell death after Pol II shutdown is… something else?
The authors show convincingly that loss of Pol II — specifically loss of one particular subunit of the machine — causes not a starvation-like death spiral but an active process of cell death called apoptosis. They erase Pol II using a few different methods, and in every case the end comes by apoptosis, before significant changes in mRNA or protein levels even happen. The authors trace the steps in the cell signaling pathway that starts with loss of Pol II and culminates in apoptosis (it’s diagrammed in their graphical abstract above).
That alone is pretty cool and new and interesting but wait — there’s more. The authors wondered if this particular death pathway is involved in cell killing by various drugs, and indeed they found that “loss of RNA Pol IIA is a common mechanism of lethality across many unrelated drug classes.” The hope is that this knowledge can help unlock insights into how better to selectively kill cancer cells.
Oh and: for some great scientific writing, enjoy this paragraph from the Discussion, which asks and answers a big question about these surprising results:
Why has this phenotype not been observed previously? Notably, the central issue is simply related to analytical resolution. Specifically, while apoptotic-deficient cells remain 100% viable following RNA Pol II degradation, these cells also cannot proliferate. Common drug response metrics misinterpret the level of lethality in this context because a non-proliferative drug-treated population is already very small compared with a rapidly dividing untreated population (Figure S1G). Furthermore, given the lack of mechanistic insight provided by conventional analysis methods, any observed difference could reasonably be interpreted as evidence that apoptosis makes a partial/negligible contribution to the lethality of transcriptional inhibition (Figure S1G).
RNA Pol II inhibition activates cell death independently from the loss of transcription
In Cell, 30 October 2025
From the group of Mike Lee at UMass Chan Medical School.
Snippet by Stephen Matheson
Image credit: graphical abstract from Harper et al. linked above (CC BY).